Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness
| Status: | Archived |
|---|---|
| Conditions: | Insomnia Sleep Studies |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | August 2010 |
| End Date: | March 2011 |
A Multiple Dose Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of ABT-652 Administered Once Daily in Subjects With an Excessive Daytime Sleepiness Disorder
The main purpose of this study is to evaluate the safety and tolerability of the drug
ABT-652 given once daily to people with excessive daytime sleepiness. Subjects will be
randomized to either ABT-652 or placebo in three sequential dosing groups for a 1-week
treatment period.
We found this trial at
5
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials